Renal Cell Carcinoma or Oncocytoma? The Contribution of Diffusion-Weighted Magnetic Resonance Imaging to the Differential Diagnosis of Renal Masses
- PMID: 35208545
- PMCID: PMC8878185
- DOI: 10.3390/medicina58020221
Renal Cell Carcinoma or Oncocytoma? The Contribution of Diffusion-Weighted Magnetic Resonance Imaging to the Differential Diagnosis of Renal Masses
Abstract
Background and Objectives: Renal Cell Carcinoma (RCC) accounts for 85% and oncocytomas constitute 3-7% of solid renal masses. Oncocytomas can be confused, especially with hypovascular RCC. The purpose of this research was to evaluate the contribution of diffusion-weighted imaging (DWI) and contrast-enhanced MRI sequences in the differential diagnosis of RCC and oncocytoma Materials and Methods: 465 patients with the diagnosis of RCC and 45 patients diagnosed with oncocytoma were retrospectively reviewed between 2009 to 2020. All MRI acquisitions were handled by a 1.5 T device (Achieva, Philips Healthcare, Best, The Netherlands) and all images were evaluated by the consensus of two radiologists with 10-15 years' experience. The SPSS package program version 15.0 software was used for statistical analysis of the study. Chi-square test, Mann-Whitney U test or the Kruskal-Wallis tests were used in the statistical analysis. A receiver operating characteristic (ROC) curve was used to calculate the cut-off values Results: The results were evaluated with a 95% confidence interval and a significance threshold of p < 0.05. ADC values (p < 0.001) and enhancement index (p < 0.01) were significantly lower in the RCC group than the oncocytoma group. Conclusion: DWI might become an alternative technique to the contrast-enhanced MRI in patients with contrast agent nephropathy or with a high risk of nephrogenic systemic fibrosis, calculation of CI of the oncocytoma and RCCs in the contrast-enhanced acquisitions would contribute to the differential diagnosis.
Keywords: ADC; DWI; carcinoma; cell; oncocytoma; renal.
Conflict of interest statement
The authors declare no conflict of interest.
Figures









Similar articles
-
The diagnostic utility of diffusion weighted MRI imaging and ADC ratio to distinguish benign from malignant renal masses: sorting the kittens from the tigers.BMC Urol. 2021 Apr 22;21(1):67. doi: 10.1186/s12894-021-00832-5. BMC Urol. 2021. PMID: 33888122 Free PMC article.
-
Diffusion-weighted imaging versus contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas.Eur Radiol. 2017 Dec;27(12):4913-4922. doi: 10.1007/s00330-017-4906-9. Epub 2017 Jun 19. Eur Radiol. 2017. PMID: 28631081
-
Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.AJR Am J Roentgenol. 2017 Apr;208(4):812-819. doi: 10.2214/AJR.16.17152. Epub 2017 Jan 26. AJR Am J Roentgenol. 2017. PMID: 28125273
-
Diagnostic test accuracy of ADC values for identification of clear cell renal cell carcinoma: systematic review and meta-analysis.Eur Radiol. 2020 Jul;30(7):4023-4038. doi: 10.1007/s00330-020-06740-w. Epub 2020 Mar 6. Eur Radiol. 2020. PMID: 32144458 Free PMC article.
-
Masses and pseudomasses of the kidney: imaging spectrum on MR.J Comput Assist Tomogr. 2004 Sep-Oct;28(5):588-95. doi: 10.1097/01.rct.0000135278.89314.60. J Comput Assist Tomogr. 2004. PMID: 15480030 Review.
References
-
- Mytsyk Y., Dutka I., Borys Y., Komnatska I., Shatynska-Mytsyk I., Farooqi A.A., Gazdikova K., Caprida M., Rodrigo L., Kruzliak P. Renal cell carcinoma: Applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade. Int. Urol. Nephrol. 2017;49:215–224. doi: 10.1007/s11255-016-1460-3. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical